These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36721665)

  • 1. Terson Syndrome - Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre.
    Lima-Fontes M; Leuzinger-Dias M; Rodrigues R; Barros-Pereira R; Falcão M; Fernandes V; Alves-Faria P; Falcão-Reis F; Rocha-Sousa A
    Clin Ophthalmol; 2023; 17():351-359. PubMed ID: 36721665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OUTCOMES OF VITRECTOMY IN TERSON SYNDROME: A Multicenter Canadian Perspective.
    Nazarali S; Kherani I; Hurley B; Williams G; Fielden M; Adatia F; Kherani A
    Retina; 2020 Jul; 40(7):1325-1330. PubMed ID: 31145391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical and functional outcomes following vitrectomy for dense vitreous hemorrhage related to Terson syndrome in children.
    Sayman Muslubas I; Karacorlu M; Hocaoglu M; Ersoz MG; Arf S
    Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):503-510. PubMed ID: 29288413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual Outcomes after Vitrectomy for Terson Syndrome Secondary to Traumatic Brain Injury.
    Narayanan R; Taylor SC; Nayaka A; Deshpande R; St Aubin D; Hrisomalos FN; Hu J; Rajagopal R; Tewari A; Apte RS
    Ophthalmology; 2017 Jan; 124(1):118-122. PubMed ID: 27817917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting anatomical and visual outcomes in Terson syndrome managed by surgery or observation.
    Gallo B; Khader R; Fajardo-Sanchez J; Sullivan P; Anikina E
    Eye (Lond); 2024 Oct; 38(14):2744-2750. PubMed ID: 38740960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome indicators for vitrectomy in Terson syndrome.
    Garweg JG; Koerner F
    Acta Ophthalmol; 2009 Mar; 87(2):222-6. PubMed ID: 18537934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed closure of macular hole secondary to Terson syndrome after vitrectomy: A case report and literature review.
    Sheng Y; Sun W; Shen Y
    Medicine (Baltimore); 2019 Aug; 98(31):e16577. PubMed ID: 31374025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terson syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage.
    Kuhn F; Morris R; Witherspoon CD; Mester V
    Ophthalmology; 1998 Mar; 105(3):472-7. PubMed ID: 9499778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual outcomes of vitrectomy for polypoidal choroidal vasculopathy-related breakthrough vitreous haemorrhage.
    Lin HC; Yang CH; Yang CM;
    Eye (Lond); 2014 Jul; 28(7):797-806; quiz 807. PubMed ID: 24924445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of dislocated intraocular lenses with iris suture.
    Faria MY; Ferreira NP; Canastro M
    Eur J Ophthalmol; 2017 Jan; 27(1):45-48. PubMed ID: 27338117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and visual prognostic indicators after vitrectomy for Terson syndrome.
    Liu X; Yang L; Cai W; Gao L; Li Y
    Eye (Lond); 2020 Apr; 34(4):650-656. PubMed ID: 31455901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcome of Pars Plana Vitrectomy for Retained Posterior Segment Intraocular Foreign Body Secondary to Gunshot Injury.
    Ghoraba HH; Leila M; Zaky AG; Elgouhary SM; Ellakwa AF; Mansour HO; Heikal MA
    Clin Ophthalmol; 2021; 15():1897-1904. PubMed ID: 33986590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitreoretinal Complications and Outcomes in 92 Eyes Undergoing Surgery for Modified Osteo-Odonto-Keratoprosthesis: A 10-Year Review.
    Rishi P; Rishi E; Agarwal V; Nair S; Iyer G; Srinivasan B; Agarwal S
    Ophthalmology; 2018 Jun; 125(6):832-841. PubMed ID: 29342438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.
    Xu K; Chin EK; Bennett SR; Williams DF; Ryan EH; Dev S; Mittra RA; Quiram PA; Davies JB; Parke DW; Johnson JB; Cantrill HL; Almeida DRP
    Ophthalmology; 2018 Aug; 125(8):1279-1286. PubMed ID: 29477689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual outcome of 25-gauge microincision vitrectomy surgery in diabetic vitreous haemorrhage.
    Khan BA; Rizvi SF; Mahmood SA; Mal W; Zafar S
    Pak J Med Sci; 2015; 31(5):1197-200. PubMed ID: 26649013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term visual outcome in Terson syndrome.
    Schultz PN; Sobol WM; Weingeist TA
    Ophthalmology; 1991 Dec; 98(12):1814-9. PubMed ID: 1775315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Referral delay and ocular surgical outcome in Terson syndrome.
    Gnanaraj L; Tyagi AK; Cottrell DG; Fetherston TJ; Richardson J; Stannard KP; Inglesby DV
    Retina; 2000; 20(4):374-7. PubMed ID: 10950415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Terson syndrome--a contribution to the timing of operation for pars plana vitrectomy].
    Augsten R; Königsdörffer E
    Klin Monbl Augenheilkd; 2007 Aug; 224(8):674-7. PubMed ID: 17717786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury.
    Czorlich P; Skevas C; Knospe V; Vettorazzi E; Richard G; Wagenfeld L; Westphal M; Regelsberger J
    Neurosurg Rev; 2015 Jan; 38(1):129-36; discussion 136. PubMed ID: 25173620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
    Gok M; Karabaş VL; Aslan MS; Kara Ö; Karaman S; Yenihayat F
    Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.